GHK-Cu
Copper Peptide Complex
Dosage
50mg / 100mg
Unit Size
1 Vial
// Add to Cart
50mg
$40.00
30 in stock
100mg
$80.00
18 in stock
What is GHK-Cu?
GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-l-histidyl-l-lysine. First isolated from human plasma in 1973, its concentration in the body declines significantly with age. It has been extensively studied for its roles in skin regeneration, wound healing, and anti-inflammatory signaling — and is uniquely capable of resetting gene expression patterns toward healthier states.
3
Amino Acid Chain
4,000+
Genes Influenced
Cu²⁺
Active Ion
Key Benefits
Collagen & Elastin Synthesis
Stimulates production of collagen and elastin, the structural proteins responsible for skin firmness and elasticity.
Wound & Skin Repair
Accelerates wound closure and supports dermal regeneration in preclinical and clinical research.
Antioxidant Activity
Exhibits potent antioxidant properties by activating free radical scavenging enzymes through copper ion activity.
Anti-Inflammatory Signaling
Downregulates pro-inflammatory cytokines, creating a more favorable environment for tissue repair.
Hair Follicle Health
Research suggests GHK-Cu may improve hair follicle density and reduce hair loss through growth factor stimulation.
Neuroprotection
Early research indicates potential neuroprotective properties through its gene-resetting capabilities.
How It Works
Gene Expression Resetting
GHK-Cu acts as a signaling molecule that modulates the expression of over 4,000 human genes, shifting them toward healthier, younger patterns.
Copper Ion Activation
The Cu²⁺ ion activates metalloenzymes involved in collagen cross-linking, antioxidant defense, and tissue remodeling.
Growth Factor Stimulation
GHK-Cu upregulates key growth factors including TGF-β, VEGF, and FGF, triggering the body's natural repair cascade.
Inflammatory Pathway Modulation
By downregulating NF-κB and TNF-α signaling, it reduces chronic inflammation that impedes tissue repair and aging.
Common Protocol (Research Reference)
1–2 mg
Dose per injection
3–5×/week
Frequency
4–8 wks
Typical cycle length
Research Use Notice
GHK-Cu is a research peptide not approved by the FDA for human use. This information is for educational purposes only. Always consult a qualified healthcare professional before considering any peptide protocol.